Skip to content

Mendelian randomization analysis using plasma proteins to identify potential drug targets for aortic aneurysm

Mendelian randomization analysis using plasma proteins to identify potential drug targets for aortic aneurysm

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089297
Enrollment
Unknown
Registered
2024-09-05
Start date
2024-09-06
Completion date
Unknown
Last updated
2024-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

aortic aneurysm

Interventions

Sponsors

Sichuan Academy of Medical Sciences · Sichuan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) diagnosed with aortic aneurysm; 2) Aged 18 years to 80 years; 3) a signed informed consent was obtained.

Exclusion criteria

Exclusion criteria: 1) life expectancy less than two years (accompanied with severe heart failure, malignant tumour, and so on); 2) pregnancy, lactation, or have a plan of fetation in two years; 3) active infection; 4) level of serum creatinine more than 212 umol/L; 5) with history of hypersensitivity to iodinated contrast media.

Design outcomes

Primary

MeasureTime frame
IL-27;GDF15;

Countries

China

Contacts

Public ContactFang Niu

Sichuan Academy of Medical Sciences · Sichuan Provincial People's Hospital

471720689@qq.com+86 187 0416 6922

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026